Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen Mackinnon

Showing results (31-40 of 106) with videos related to

Pageof 11
Sort By:
British Journal of Haematology|December 17, 2011
Predominant or complete recipient T-cell chimerism following alemtuzumab-based allogeneic transplantation is reversed by donor lymphocytes and not associated with graft failureSajir G Mohamedbhai, Noha Edwards, Emma C Morris, et al.
Journal of Consulting and Clinical Psychology|July 11, 2006
Contingency management treatments: Reinforcing abstinence versus adherence with goal-related activitiesNancy M Petry, Sheila M Alessi, Kathleen M Carroll, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|February 19, 2003
Development and clinical application of a fully controlled quantitative PCR assay for cell-free cytomegalovirus in human plasmaWolfgang Preiser, Nicola S Brink, Ursula Ayliffe, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 10, 2006
The importance of age, fludarabine, and total body irradiation in the incidence and severity of chronic renal failure after allogeneic hematopoietic cell transplantationJulio Delgado, Nichola Cooper, Kirsty Thomson, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 26, 2003
Reconstitution of T-cell repertoire after autologous stem cell transplantation: influence of CD34 selection and cytomegalovirus infectionKarl S Peggs, Stephanie Verfuerth, Arnold Pizzey, et al.
British Journal of Haematology|August 24, 2017
Real world data of the impact of first cycle daratumumab on multiple myeloma and AL amyloidosis servicesRakesh Popat, Emma Dowling, Sufyan Achhala, et al.
Blood|June 26, 2010
The role of Vδ2-negative γδ T cells during cytomegalovirus reactivation in recipients of allogeneic stem cell transplantationAndrea Knight, Alejandro J Madrigal, Sarah Grace, et al.
Blood|June 18, 2002
Outcome of major ABO-incompatible nonmyeloablative hematopoietic stem cell transplantation may be influenced by conditioning regimenKarl S Peggs, Emma C Morris, Panos D Kottaridis, et al.
Haematologica|May 15, 2003
Allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning in acute lymphoblastic leukemia: a feasibility studyRodrigo Martino, Sergio Giralt, María Dolores Caballero, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 15, 2010
Directly selected cytomegalovirus-reactive donor T cells confer rapid and safe systemic reconstitution of virus-specific immunity following stem cell transplantationKarl S Peggs, Kirsty Thomson, Edward Samuel, et al.
Pageof 11

Showing results (31-40 of 106) with videos related to

Sort By:
Pageof 11
British Journal of Haematology|December 17, 2011
Predominant or complete recipient T-cell chimerism following alemtuzumab-based allogeneic transplantation is reversed by donor lymphocytes and not associated with graft failureSajir G Mohamedbhai, Noha Edwards, Emma C Morris, et al.
Journal of Consulting and Clinical Psychology|July 11, 2006
Contingency management treatments: Reinforcing abstinence versus adherence with goal-related activitiesNancy M Petry, Sheila M Alessi, Kathleen M Carroll, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|February 19, 2003
Development and clinical application of a fully controlled quantitative PCR assay for cell-free cytomegalovirus in human plasmaWolfgang Preiser, Nicola S Brink, Ursula Ayliffe, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 10, 2006
The importance of age, fludarabine, and total body irradiation in the incidence and severity of chronic renal failure after allogeneic hematopoietic cell transplantationJulio Delgado, Nichola Cooper, Kirsty Thomson, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 26, 2003
Reconstitution of T-cell repertoire after autologous stem cell transplantation: influence of CD34 selection and cytomegalovirus infectionKarl S Peggs, Stephanie Verfuerth, Arnold Pizzey, et al.
British Journal of Haematology|August 24, 2017
Real world data of the impact of first cycle daratumumab on multiple myeloma and AL amyloidosis servicesRakesh Popat, Emma Dowling, Sufyan Achhala, et al.
Blood|June 26, 2010
The role of Vδ2-negative γδ T cells during cytomegalovirus reactivation in recipients of allogeneic stem cell transplantationAndrea Knight, Alejandro J Madrigal, Sarah Grace, et al.
Blood|June 18, 2002
Outcome of major ABO-incompatible nonmyeloablative hematopoietic stem cell transplantation may be influenced by conditioning regimenKarl S Peggs, Emma C Morris, Panos D Kottaridis, et al.
Haematologica|May 15, 2003
Allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning in acute lymphoblastic leukemia: a feasibility studyRodrigo Martino, Sergio Giralt, María Dolores Caballero, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 15, 2010
Directly selected cytomegalovirus-reactive donor T cells confer rapid and safe systemic reconstitution of virus-specific immunity following stem cell transplantationKarl S Peggs, Kirsty Thomson, Edward Samuel, et al.
Pageof 11